New Members Deepen Research & Investment Expertise of ADDF Boards


At the December joint meeting, the ADDF Boards of Governors and Overseers welcomed seven new members.

Margaret and Daniel Loeb Honored at Our Sixth Annual Fall Symposium & Luncheon


On Monday, November 9, Margaret and Daniel Loeb received The Charles Evans Award from the ADDF at our Sixth Annual Fall Symposium & Luncheon. Thanks to the generosity of our donors, the Symposium & Luncheon raised more than $1 million, the most in the event’s history.

New Grant Supports Alzecure’s Work on Neurorestorative Drug


AlzeCure Foundation announced today that it has been awarded a grant from the ADDF to support the further development of its small molecule neurorestorative project.

Dr. Frank Longo Wins Inaugural Melvin R. Goodes Prize


Dr. Longo’s pioneering approach may soon lead to new disease modifying drugs.

Register Today for the Hope Flies Health Series Webinar


The Foundation for Mitochondrial Medicine (FMM) is hosting its Hope Flies Health Series Webinar: Research Connecting Alzheimer’s and Mitochondrial Disease on Wednesday, September 23, 2015. The Foundation developed the webinar with partners including the ADDF, MitoAction and Sharecare to particularly bring greater awareness to mitochondrial disease in conjunction with Global Mitochondrial Disease Awareness Week. 

ADDF and Harrington Discovery Institute Announce 2015 Award Recipients


Collaboration advances development of therapeutics for the treatment of Alzheimer’s Disease.

ADDF to be Featured in Upcoming Episode of Innovations with Ed Begley Jr.


The ADDF will be featured in an upcoming episode of Innovations with Ed Begley Jr., airing via Discovery Channel later this year. 

Goodes Family & The ADDF Create New Prize for Alzheimer’s Drug Development Researchers


Melvin R. Goodes Prize supports innovative projects by top researchers while honoring pioneering legacy of former Warner-Lambert CEO.

Carmel Valley, California Winery Launches Two New Wines to Benefit the ADDF


Carmel Valley's newest winery, Jarman Wines, will introduce two premium varietals to benefit the Alzheimer's Drug Discovery Foundation (ADDF) and to honor the matriarch of the family whose name graces the wines created for her.

Grantees at Lou Rovo Center for Brain Health Recruiting for New Alzheimer’s Disease Trial


Cleveland Clinic Lou Ruvo Center for Brain Health is now recruiting participants for a new, multicenter Alzheimer’s disease (AD) treatment trial, Rasagiline Rescue (R2), which is designed to determine if treatment with rasagiline is associated with improved brain glucose metabolism and improvement in memory.